Ovid Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
OVID Key Statistics
Stock Snapshot
With a market cap of 298.77M, Ovid Therapeutics(OVID) trades at $2.30. The stock has a price-to-earnings ratio of -3.93.
As of 2026-03-18, Ovid Therapeutics(OVID) stock has fluctuated between $2.09 and $2.94. The current price stands at $2.30, placing the stock +9.8% above today's low and -21.9% off the high.
Ovid Therapeutics(OVID) shares are trading with a volume of 39.87M, against a daily average of 2.6M.
In the last year, Ovid Therapeutics(OVID) shares hit a 52-week high of $2.94 and a 52-week low of $0.24.
In the last year, Ovid Therapeutics(OVID) shares hit a 52-week high of $2.94 and a 52-week low of $0.24.
OVID News
Ovid Therapeutics (OVID +12.93%) stock rose by more than 18% as of 12 a.m. today. The biopharmaceutical company is devoted to developing medicines for people wi...
Ovid Therapeutics (OVID) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.1 per share. This compares to...
Ovid Therapeutics (OVID) shares jumped over 40% premarket as the biopharmaceutical company reported favorable safety and tolerability results for the 7 mg dose...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.